1. Home
  2. YJ vs VRAX Comparison

YJ vs VRAX Comparison

Compare YJ & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • VRAX
  • Stock Information
  • Founded
  • YJ 2015
  • VRAX 2013
  • Country
  • YJ China
  • VRAX United Kingdom
  • Employees
  • YJ N/A
  • VRAX N/A
  • Industry
  • YJ Other Specialty Stores
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • YJ Consumer Discretionary
  • VRAX Health Care
  • Exchange
  • YJ Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • YJ 8.8M
  • VRAX 7.3M
  • IPO Year
  • YJ 2019
  • VRAX 2022
  • Fundamental
  • Price
  • YJ $1.76
  • VRAX $1.90
  • Analyst Decision
  • YJ
  • VRAX
  • Analyst Count
  • YJ 0
  • VRAX 0
  • Target Price
  • YJ N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • YJ 37.0K
  • VRAX 282.7K
  • Earning Date
  • YJ 03-20-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • YJ N/A
  • VRAX N/A
  • EPS Growth
  • YJ N/A
  • VRAX N/A
  • EPS
  • YJ N/A
  • VRAX N/A
  • Revenue
  • YJ $66,957,730.00
  • VRAX $84,872.00
  • Revenue This Year
  • YJ N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • YJ N/A
  • VRAX $66.97
  • P/E Ratio
  • YJ N/A
  • VRAX N/A
  • Revenue Growth
  • YJ N/A
  • VRAX 7.03
  • 52 Week Low
  • YJ $1.42
  • VRAX $0.60
  • 52 Week High
  • YJ $4.72
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • YJ 50.71
  • VRAX 49.13
  • Support Level
  • YJ $1.65
  • VRAX $1.58
  • Resistance Level
  • YJ $1.75
  • VRAX $2.10
  • Average True Range (ATR)
  • YJ 0.12
  • VRAX 0.25
  • MACD
  • YJ -0.01
  • VRAX 0.01
  • Stochastic Oscillator
  • YJ 39.29
  • VRAX 47.88

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: